A multi-centre phase 2 study of azacitidine in chronic myelomonocytic leukaemia

Affiliations

¹ Beatson West of Scotland Cancer Centre and University of Glasgow, Glasgow, UK.
² Department of Hematology, East Kent Hospitals, Canterbury, UK.
³ Leeds Institute for Cancer Studies and Pathology, University of Leeds, Leeds, UK.
⁴ Worcestershire Acute Hospitals NHS Trust and University of Birmingham, Birmingham, UK.
⁵ Clinical Trials Research Unit, University of Leeds, Leeds, UK.
⁶ Institute of Biomedical Research, University of Birmingham, Birmingham, UK.
⁷ Faculty of Medicine, University of Southampton, Southampton, UK.
⁸ Department of Hematology, University Hospital of Wales, Cardiff, UK.
⁹ Department of Hematology, St James's Institute of Oncology, Leeds, UK.

Clinical Trial

M W Drummond et al. Leukemia. 2014 Jul.

. 2014 Jul;28(7):1570-2.

doi: 10.1038/leu.2014.85. Epub 2014 Feb 26.

¹ Beatson West of Scotland Cancer Centre and University of Glasgow, Glasgow, UK.
² Department of Hematology, East Kent Hospitals, Canterbury, UK.
³ Leeds Institute for Cancer Studies and Pathology, University of Leeds, Leeds, UK.
⁴ Worcestershire Acute Hospitals NHS Trust and University of Birmingham, Birmingham, UK.
⁵ Clinical Trials Research Unit, University of Leeds, Leeds, UK.
⁶ Institute of Biomedical Research, University of Birmingham, Birmingham, UK.
⁷ Faculty of Medicine, University of Southampton, Southampton, UK.
⁸ Department of Hematology, University Hospital of Wales, Cardiff, UK.
⁹ Department of Hematology, St James's Institute of Oncology, Leeds, UK.

No abstract available

References